drugset / Trial / NCT00350480

Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial

NCT00350480

Completed 240 enrolled Kaiser Permanente
RandomizedParallel-groupOpen-labelTreatment

Summary

To determine the relative efficacy of multidose medroxyprogesterone acetate (MPA, Provera) and a multidose, monophasic combination oral contraceptive in the treatment of hemodynamically stable women with non-gestational, acute uterine bleeding.

Timeline

Start
2003-04
Primary completion
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Norethindrone Unknown 1 mg Oral
Subject ethinyl estradiol Small molecule 35 ug Oral
Subject medroxyprogesterone acetate Other / unclassified 20 mg Oral